Vascular Access Devices Market to Hit US$9.05 Billion by 2030 with 7.1% CAGR | MarketsandMarkets™
The global vascular access devices market, valued at US$5.60 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, ...
BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment
BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESREMi faces competition from drugs like ruxolitinib, a ...
FiercePharma2d
Argenx banks on key prefilled syringe approval for Vyvgart to help drive profitability in 2025: exec
Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a ...
Medscape2d
Intravenous to Subcutaneous Infliximab Switch Shows Promise in IBD Management
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...